Hirota Y, Matsumoto I, Takata K, Kondou S, Aso T, Hino H, Nishiura S, Makuuchi M
Dept. of Int. Med., Matsuyama Red Cross Hospital.
Gan No Rinsho. 1989 Aug;35(9):1073-6.
Acute myeloblastic leukemia (AML) was diagnosed in a 54-year-old male who had been known to carry a chronic hepatitis B surface antigen (HBsAg) from June, 1983. Prompt remission was achieved with combination chemotherapy of BHAC-DMP. Follow-up maintenance and an intensification of this chemotherapy had been given for five years. He was readmitted to our hospital in March, 1988 because a mass was detected in the right lobe of the liver by ultrasonography. His serum alpha fetoprotein (AFP) level was found to be 180.1 ng/ml, and was diagnosed as having a hepatocellular carcinoma though there was no evidence of liver cirrhosis. A curative right hepatectomy was performed in May, 1988 after transcatheter arterial embolization and portal embolization. After resection of the tumor, the AFP level decreased to 10.7 ng/ml and no HbsAg was detected in the serum.
一名54岁男性被诊断为急性髓细胞白血病,该患者自1983年6月起已知携带慢性乙型肝炎表面抗原(HBsAg)。通过BHAC - DMP联合化疗迅速实现缓解。随后进行了五年的后续维持和强化化疗。1988年3月,他因超声检查发现肝脏右叶有肿块而再次入院。其血清甲胎蛋白(AFP)水平为180.1 ng/ml,虽无肝硬化证据,但被诊断为肝细胞癌。1988年5月,在经导管动脉栓塞和门静脉栓塞后进行了根治性右肝切除术。肿瘤切除后,AFP水平降至10.7 ng/ml,血清中未检测到HbsAg。